Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response
Open accessThe DOI matches its Crossref record; 162 of the 162 references it cites were found in a registry or an index.
Abstract
Hypoxia and free radicals, such as reactive oxygen and nitrogen species, can alter the function and/or activity of the transcription factor hypoxia-inducible factor 1 (HIF1). Interplay between free radicals, hypoxia and HIF1 activity is complex and can influence the earliest stages of tumour development. The hypoxic environment of tumours is heterogeneous, both spatially and temporally, and can change in response to cytotoxic therapy. Free radicals created by hypoxia, hypoxia-reoxygenation cycling and immune cell infiltration after cytotoxic therapy strongly influence HIF1 activity. HIF1 can then promote endothelial and tumour cell survival. As discussed here, a constant theme emerges: inhibition of HIF1 activity will have therapeutic benefit.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many human cancers contain regions of hypoxia because of rapid cell proliferation and the presence of intratumoral blood vessels that are structurally and functionally abnormal, resulting in both spatial and temporal heterogeneity of blood flow (1, 2).”
From Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth (2008) · cites this paper as [2]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“ROS production later stabilizes the HIF-1α protein and increases expression of HIF-1α and its target genes (Moeller et al., 2004;Dewhirst et al., 2008;Harada et al., 2009).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Dewhirst et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kasuno, K., Takabuchi, S., Fukuda, K., Kizaka-Kondoh, S., Yodoi, J., Adachi, T., Semenza, G. L., & Hirota, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308197200 · Cited by 226
RetractedPlum, F. (1960) · Archives of Neurology · doi:10.1001/archneur.1960.03840090124020 · Cited by 10,364
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535 · cited 1×
“The HIF1α subunit is exquisitely regulated by hydroxylation of proline residues in its oxygen-dependent degradation domain (ODD) that target it for recognition by the von Hippel Lindau (VHL) complex and subsequent proteasomal degradation under aerobic condition”
BackgroundThe tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828 · cited 1×
“Origins of hypoxia in solid tumours The presence of hypoxia in tumours is a well-established source of resistance to radiation therapy and chemotherap”
Background
Cited by
Items 101–200 of 999
Nanoparticle‐Mediated Radiotherapy Remodels the Tumor Microenvironment to Enhance Antitumor Efficacy
Zhen, W., Weichselbaum, R. R., & Lin, W. (2023) · Advanced Materials · doi:10.1002/adma.202206370 · Cited by 177
Rofstad, E. K., Gaustad, J., Egeland, T. A. M., Mathiesen, B., & Galappathi, K. (2010) · International Journal of Cancer · doi:10.1002/ijc.25176 · Cited by 173
Molecular targeting of hypoxia in radiotherapy
Rey, S., Schito, L., Koritzinsky, M., & Wouters, B. G. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.10.002 · Cited by 172
“(reviewed in [145]) Consistently, genetic knockdown of NOX4 enhances radiosensitivity promoted by intermittent hypoxia [146] whereas pharmacological inhibition of HIF-1α impairs the induction of the multidrug resistance (MDR)-1 transporter (encoded by ABCB1), resulting in decreased chemoresistance in glioblastoma orth…”
BackgroundHuo, D., Liu, S., Zhang, C., He, J., Zhou, Z., Zhang, H., & Hu, Y. (2017) · ACS Nano · doi:10.1021/acsnano.7b04737 · Cited by 172
Ways to Enhance Lymphocyte Trafficking into Tumors and Fitness of Tumor Infiltrating Lymphocytes
Bellone, M., & Calcinotto, A. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00231 · Cited by 167
Negative Regulation of Hypoxic Responses via Induced Reptin Methylation
Lee, J. S., Kim, Y., Kim, I. S., Kim, B., Choi, H. J., Lee, J. M., Shin, H.-J. R., Kim, J. H., Kim, J.-Y., Seo, S.-B., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.008 · Cited by 166
Oxidative stress in cancer: from tumor and microenvironment remodeling to therapeutic frontiers
Liang, X., Weng, J., You, Z., Wang, Y., Wen, J., Xia, Z., Huang, S., Luo, P., & Cheng, Q. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02375-x · Cited by 220
How Can We Overcome Tumor Hypoxia in Radiation Therapy?
HARADA, H. (2011) · Journal of Radiation Research · doi:10.1269/jrr.11056 · Cited by 164
Glycolytic enzyme inhibitors in cancer treatment
Scatena, R., Bottoni, P., Pontoglio, A., Mastrototaro, L., & Giardina, B. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.10.1533 · Cited by 164
Span, P. N., & Bussink, J. (2015) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2014.10.002 · Cited by 163
Philip, B., Ito, K., Moreno-Sanchez, R., & Ralph, S. J. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt209 · Cited by 161
Dual roles of NRF2 in tumor prevention and progression: Possible implications in cancer treatment
Moon, E. J., & Giaccia, A. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.11.009 · Cited by 160
Wang, P., Li, X., Yao, C., Wang, W., Zhao, M., El-Toni, A. M., & Zhang, F. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.02.017 · Cited by 160
Hirayama, T., Tsuboi, H., Niwa, M., Miki, A., Kadota, S., Ikeshita, Y., Okuda, K., & Nagasawa, H. (2017) · Chemical Science · doi:10.1039/c6sc05457a · Cited by 158
Angiogenesis and liver fibrosis
Elpek, G. Ö. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i3.377 · Cited by 178
Nanomedicine‐Boosting Tumor Immunogenicity for Enhanced Immunotherapy
Huang, J., Yang, B., Peng, Y., Huang, J., Wong, S. H. D., Bian, L., Zhu, K., Shuai, X., & Han, S. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202011171 · Cited by 157
Microenvironment and Radiation Therapy
Yoshimura, M., Itasaka, S., Harada, H., & Hiraoka, M. (2013) · BioMed Research International · doi:10.1155/2013/685308 · Cited by 156
KATOH, M. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1444 · Cited by 156
Conjugated Photosensitizers for Imaging and PDT in Cancer Research
Simões, J. C. S., Sarpaki, S., Papadimitroulas, P., Therrien, B., & Loudos, G. K. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00047 · Cited by 171
Kabakov, A. E., & Yakimova, A. O. (2021) · Cancers · doi:10.3390/cancers13051102 · Cited by 180
Targeting the Metabolic Microenvironment of Tumors
Bailey, K. M., Wojtkowiak, J. W., Hashim, A. I., & Gillies, R. J. (2012) · Advances in Pharmacology · doi:10.1016/b978-0-12-397927-8.00004-x · Cited by 154
Radiation effects on the tumor microenvironment: Implications for nanomedicine delivery
Stapleton, S., Jaffray, D. A., & Milosevic, M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.05.021 · Cited by 168
Hyperthermia can alter tumor physiology and improve chemo- and radio-therapy efficacy
Dunne, M., Regenold, M., & Allen, C. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.007 · Cited by 150
Cellular and molecular mechanisms in the hypoxic tissue: role of HIF‐1 and ROS
Zepeda, A. B., Pessoa, A., Castillo, R. L., Figueroa, C. A., Pulgar, V. M., & Farías, J. G. (2013) · Cell Biochemistry and Function · doi:10.1002/cbf.2985 · Cited by 149
Unfolded protein response (UPR) integrated signaling networks determine cell fate during hypoxia
Bartoszewska, S., & Collawn, J. F. (2020) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-020-00212-1 · Cited by 146
The Endothelium as a Driver of Liver Fibrosis and Regeneration
Lafoz, E., Ruart, M., Anton, A., Oncins, A., & Hernández-Gea, V. (2020) · Cells · doi:10.3390/cells9040929 · Cited by 149
Exercise as adjunct therapy in cancer
Ashcraft, K. A., Warner, A. B., Jones, L. W., & Dewhirst, M. W. (2019) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2018.10.001 · Cited by 148
Self-citationTargeting a cornerstone of radiation resistance: cancer stem cell.
Moncharmont, C., Lévy, A., Gilormini, M., Bertrand, G., Chargari, C., Alphonse, G., Ardail, D., Rodriguez-Lafrasse, C., & Magné, N. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.03.024 · Cited by 149
“shown to correlate to tumor radiation resistance [42,43].”
BackgroundJones, L. W., Fels, D. R., West, M., Allen, J. D., Broadwater, G., Barry, W. T., Wilke, L. G., Masko, E., Douglas, P. S., Dash, R. C., et al. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0416 · Cited by 145
Self-citationMatsumoto, S., Yasui, H., Mitchell, J. B., & Krishna, M. C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2821 · Cited by 144
Crosstalk between Notch, HIF-1α and GPER in Breast Cancer EMT
De Francesco, E. M., Maggiolini, M., & Musti, A. M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19072011 · Cited by 142
Autophagy is required during cycling hypoxia to lower production of reactive oxygen species
Rouschop, K. M. A., Ramaekers, C. H. M. A., Schaaf, M. B. E., Keulers, T. G., Savelkouls, K. G. M., Lambin, P., Koritzinsky, M., & Wouters, B. G. (2009) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2009.06.029 · Cited by 153
Hypoxia-induced metabolic shifts in cancer cells: Moving beyond the Warburg effect
Weljie, A. M., & Jirik, F. R. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.08.009 · Cited by 155
Two-stage oxygen delivery for enhanced radiotherapy by perfluorocarbon nanoparticles
Zhou, Z., Zhang, B., Wang, H., Yuan, A., Hu, Y., & Wu, J. (2018) · Theranostics · doi:10.7150/thno.27598 · Cited by 139
Anticancer drugs that target metabolism: Is dichloroacetate the new paradigm?
Papandreou, I., Golias, T., & Denko, N. C. (2010) · International Journal of Cancer · doi:10.1002/ijc.25728 · Cited by 163
Martínez‐González, A., Calvo, G. F., Pérez-Romasanta, L. A., & Pérez‐García, V. M. (2012) · Bulletin of Mathematical Biology · doi:10.1007/s11538-012-9786-1 · Cited by 144
Differential Hypoxic Regulation of Hypoxia-Inducible Factors 1α and 2α
Lin, Q., Cong, X., & Yun, Z. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0053 · Cited by 132
Sensitization of Glioblastoma Cells to Irradiation by Modulating the Glucose Metabolism
Shen, H. M., Hau, E. K. C., Joshi, S. M., Dilda, P. J., & McDonald, K. L. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0247 · Cited by 142
Takahashi, S., Piao, W., Matsumura, Y., Komatsu, T., Ueno, T., Terai, T., Kamachi, T., Kohno, M., Nagano, T., & Hanaoka, K. (2012) · Journal of the American Chemical Society · doi:10.1021/ja310049d · Cited by 133
Improving efficacy of hyperthermia in oncology by exploiting biological mechanisms
van den Tempel, N., Horsman, M. R., & Kanaar, R. (2016) · International Journal of Hyperthermia · doi:10.3109/02656736.2016.1157216 · Cited by 137
Tameire, F., Verginadis, I. I., & Koumenis, C. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.04.002 · Cited by 129
“ycling hypoxia that is characterized by oxygen deprivation and e-oxygenation creates increased ROS levels in hypoxic cells [70].”
BackgroundMatsumoto, S., Batra, S., Saito, K., Yasui, H., Choudhuri, R., Gadisetti, C., Subramanian, S., Devasahayam, N., Munasinghe, J. P., Mitchell, J. B., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2025 · Cited by 129
Chamboredon, S., Ciais, D., Desroches-Castan, A., Savi, P., Bono, F., Feige, J.-J., & Cherradi, N. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-07-0617 · Cited by 126
Yang, J., Li, W., Luo, L., Jiang, M., Zhu, C., Qin, B., Yin, H., Yuan, X., Yin, X., Zhang, J., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.08.004 · Cited by 127
Wang, H., Guo, Y., Wang, C., Jiang, X., Liu, H., Yuan, A., Yan, J., Hu, Y., & Wu, J. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2020.120621 · Cited by 124
Cao, H., Wang, L., Yang, Y., Li, J., Qi, Y., Li, Y., Li, Y., Wang, H., & Li, J. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201802497 · Cited by 126
Chitneni, S. K., Palmer, G. M., Zalutsky, M. R., & Dewhirst, M. W. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.075663 · Cited by 137
Self-citationGalectin-1 as a potent target for cancer therapy: role in the tumor microenvironment
Ito, K., Stannard, K. A., Gabutero, E., Clark, A. M., Neo, S., Onturk, S., Blanchard, H., & Ralph, S. J. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9388-2 · Cited by 148
ACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using 18F-FMISO PET and MRI
Gerstner, E. R., Zhang, Z., Fink, J. R., Muzi, M., Hanna, L., Greco, E., Prah, M., Schmainda, K. M., Mintz, A., Kostakoglu, L., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2529 · Cited by 122
Hunyor, I., & Cook, K. M. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00036.2018 · Cited by 134
Policastro, L. L., Ibañez, I. L., Notcovich, C., Duran, H. A., & Podhajcer, O. L. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4367 · Cited by 120
Controlled Delivery of Nitric Oxide for Cancer Therapy
Alimoradi, H., Greish, K. F., Gamble, A. B., & Giles, G. I. (2019) · Pharmaceutical Nanotechnology · doi:10.2174/2211738507666190429111306 · Cited by 126
Bader, S. B., Dewhirst, M. W., & Hammond, E. M. (2020) · Cancers · doi:10.3390/cancers13010023 · Cited by 141
Self-citationHu, S., Feng, J., Wang, M., Wufuer, R., Liu, K., Zhang, Z., & Zhang, Y. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102470 · Cited by 136
Carbonic Anhydrase IX as an Imaging and Therapeutic Target for Tumors and Metastases
Tafreshi, N. K., Lloyd, M. C., Bui, M. M., Gillies, R. J., & Morse, D. L. (2013) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-7359-2_12 · Cited by 131
Mechanisms Contributing to the Comorbidity of COPD and Lung Cancer
Forder, A., Zhuang, R., Souza, V. G. P., Brockley, L. J., Pewarchuk, M. E., Telkar, N., Stewart, G. L., Benard, K., Marshall, E. A., Reis, P. P., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032859 · Cited by 136
Recchia, A. G., De Francesco, E. M., Vivacqua, A., Sisci, D., Panno, M. L., Andò, S., & Maggiolini, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.172247 · Cited by 116
Acute Versus Chronic Hypoxia: Why a Simplified Classification is Simply Not Enough
Bayer, C., Shi, K., Astner, S. T., Maftei, C.-A., & Vaupel, P. W. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.02.049 · Cited by 115
Adipose-Derived Stem Cells in Radiotherapy Injury: A New Frontier
Shukla, L., Morrison, W. A., & Shayan, R. (2015) · Frontiers in Surgery · doi:10.3389/fsurg.2015.00001 · Cited by 115
Wang, Y., Wu, W., Mao, D., Teh, C., Wang, B., & Liu, B. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202002431 · Cited by 114
Immunologically augmented cancer treatment using modern radiotherapy
Durante, M., Reppingen, N., & Held, K. D. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.05.007 · Cited by 132
Zhang, Y., Ji, W., Lian, H., Chen, Y., Ding, X., Sun, Y., Hu, S., Yang, H., Huang, W. T., Zhang, Y., et al. (2018) · Theranostics · doi:10.7150/thno.21575 · Cited by 121
Nanoparticle Interactions with the Tumor Microenvironment
Huai, Y., Hossen, M. N., Wilhelm, S., Bhattacharya, R., & Mukherjee, P. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00448 · Cited by 113
Tumor Dormancy and Interplay with Hypoxic Tumor Microenvironment
Butturini, E., Carcereri de Prati, A., Boriero, D., & Mariotto, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174305 · Cited by 113
“Cycling hypoxia results in an enhanced activity and stabilization of HIF-1α, which is at a much greater level than that in chronic hypoxia [30].”
BackgroundHsieh, C.-H., Shyu, W.-C., Chiang, C.-Y., Kuo, J.-W., Shen, W.-C., & Liu, R.-S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023945 · Cited by 111
Tumor Cells Upregulate Normoxic HIF-1α in Response to Doxorubicin
Cao, Y., Eble, J. M., Moon, E., Yuan, H., Weitzel, D. H., Landon, C. D., Yu-Chih Nien, C., Hanna, G., Rich, J. N., Provenzale, J. M., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-1345 · Cited by 111
Self-citationRezaeian, A.-H., Li, C.-F., Wu, C.-Y., Zhang, X., Delacerda, J., You, M. J., Han, F., Cai, Z., Jeong, Y. S., Jin, G., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3445 · Cited by 109
Katoh (2009) · International Journal of Oncology · doi:10.3892/ijo_00000304 · Cited by 118
van Rooijen, E., Voest, E. E., Logister, I., Bussmann, J., Korving, J., van Eeden, F. J., Giles, R. H., & Schulte‐Merker, S. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.004036 · Cited by 110
Oxygen-Guided Radiation Therapy
Epel, B., Maggio, M. C., Barth, E. D., Miller, R. C., Pelizzari, C. A., Krzykawska-Serda, M., Sundramoorthy, S. V., Aydogan, B., Weichselbaum, R. R., Tormyshev, V. M., et al. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.10.041 · Cited by 112
Tumor microenvironment-responsive dynamic inorganic nanoassemblies for cancer imaging and treatment
Yang, Y. P., Wu, H., Liu, B., & Liu, Z. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114004 · Cited by 107
Padhani, A. R., & Khan, A. A. (2010) · Targeted Oncology · doi:10.1007/s11523-010-0135-8 · Cited by 111
Effect of Pazopanib on Tumor Microenvironment and Liposome Delivery
Tailor, T. D., Hanna, G., Yarmolenko, P. S., Dreher, M. R., Betof, A. S., Nixon, A. B., Spasojevic, I., & Dewhirst, M. W. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0856 · Cited by 106
Self-citationKrutilina, R., Sun, W., Sethuraman, A., Brown, M., Seagroves, T. N., Pfeffer, L. M., Ignatova, T., & Fan, M. (2014) · Breast Cancer Research · doi:10.1186/bcr3693 · Cited by 105
The controversial place of vitamin C in cancer treatment
Verrax, J., & Calderón, P. B. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.09.024 · Cited by 117
Monitoring Intracellular Redox Potential Changes Using SERS Nanosensors
Auchinvole, C. A. R., Richardson, P., McGuinnes, C., Mallikarjun, V., Donaldson, K., McNab, H., & Campbell, C. J. (2012) · ACS Nano · doi:10.1021/nn204397q · Cited by 103
Tao, J.-H., Barbi, J. J., & Pan, F. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00204.2015 · Cited by 112
Hypoxia-driven immunosuppression: A new reason to use thermal therapy in the treatment of cancer?
Lee, C.-T., Mace, T., & Repasky, E. A. (2010) · International Journal of Hyperthermia · doi:10.3109/02656731003601745 · Cited by 103
Rabbani, Z. N., Spasojevic, I., Zhang, X., Moeller, B. J., Haberle, S., Vasquez-Vivar, J., Dewhirst, M. W., Vujaskovic, Z., & Batinic-Haberle, I. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.07.001 · Cited by 103
Self-citationRen, S., Wang, B., Zhu, X., Zhu, D. Y., Liu, M., Li, S., Yang, Y., Wang, Z., & Zhu, H. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c08534 · Cited by 105
Harrison, J. F., & Haddad, G. G. (2011) · Annual Review of Physiology · doi:10.1146/annurev-physiol-012110-142155 · Cited by 109
Supramolecular Nitric Oxide Depot for Hypoxic Tumor Vessel Normalization and Radiosensitization
Yang, C., Mu, G., Zhang, Y., Gao, Y., Zhang, W., Liu, J., Zhang, W., Li, P., Yang, L., Yang, Z., et al. (2022) · Advanced Materials · doi:10.1002/adma.202202625 · Cited by 104
Pim-1 plays a pivotal role in hypoxia-induced chemoresistance
Chen, J., Kobayashi, M., Darmanin, S., Qiao, Y., Gully, C., Zhao, R., Yeung, S. C., & Lee, M. H. (2009) · Oncogene · doi:10.1038/onc.2009.124 · Cited by 101
Tomaszewski, M. R., Quirós-González, I., O’Connor, J. P. B., Abeyakoon, O., Parker, G. J. M., Williams, K. J., Gilbert, F. J., & Bohndiek, S. E. (2017) · Theranostics · doi:10.7150/thno.19841 · Cited by 101
Mujčić, H., Rzymski, T., Rouschop, K. M. A., Koritzinsky, M., Milani, M., Harris, A. L., & Wouters, B. G. (2009) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2009.08.017 · Cited by 111
“However, tumour hypoxia can arise directly around or near to vessels due to transient changes in blood perfusion [46].”
BackgroundPINCH1 regulates Akt1 activation and enhances radioresistance by inhibiting PP1α
Eke, I., Koch, U., Hehlgans, S., Sandfort, V., Stanchi, F., Zips, D., Baumann, M., Shevchenko, A., Pilarsky, C., Haase, M., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41078 · Cited by 97
Feng, Y., Liao, Z., Li, M., Zhang, H., Li, T., Qin, X., Li, S., Wu, C., You, F., Liao, X., et al. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202201884 · Cited by 105
Physiologic hypoxia promotes maintenance of CML stem cells despite effective BCR-ABL1 inhibition
Ng, K. P., Manjeri, A., Lee, K. L., Huang, W., Tan, S. Y., Chuah, C. T. H., Poellinger, L., & Ong, S. T. (2014) · Blood · doi:10.1182/blood-2013-07-511907 · Cited by 97
Zhang, C., Xia, D., Liu, J., Huo, D., Jiang, X., & Hu, Y. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202000189 · Cited by 100
The impact of hypoxia in pancreatic cancer invasion and metastasis
Díaz, B., & Yuen, A. (2014) · Hypoxia · doi:10.2147/hp.s52636 · Cited by 120
Platelet–neutrophil interactions under thromboinflammatory conditions
Li, J., Kim, K., Barazia, A., Tseng, A., & Cho, J. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1845-y · Cited by 107
Reece, K. M., Richardson, E. D., Cook, K. M., Campbell, T. J., Pisle, S. T., Holly, A. J., Venzon, D. J., Liewehr, D. J., Chau, C. H., Price, D. K., et al. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-91 · Cited by 104
Imaging Tumor Hypoxia to Advance Radiation Oncology
Lee, C.-T., Boss, M., & Dewhirst, M. W. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5759 · Cited by 108
Self-citationHao, X., Ren, Y., Feng, M., Wang, Q., & Wang, Y. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111798 · Cited by 106
Cytosolic Phospholipase A2 and Lysophospholipids in Tumor Angiogenesis
Linkous, A. G., Yazlovitskaya, E. M., & Hallahan, D. E. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq290 · Cited by 96
Wei, Z., Shan, Y., Li, T., Liu, Y., Zhu, Z., Liu, Z., Wu, Y., Chen, W., Wang, A., & Lu, Y. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22686 · Cited by 101
Characterization of Lipid and Lipid Droplet Metabolism in Human HCC
Berndt, N., Eckstein, J., Heucke, N., Gajowski, R., Stockmann, M., Meierhofer, D., & Holzhütter, H. (2019) · Cells · doi:10.3390/cells8050512 · Cited by 98
Nrf2 in ischemic neurons promotes retinal vascular regeneration through regulation of semaphorin 6A
Wei, Y., Gong, J., Xu, Z., Thimmulappa, R. K., Mitchell, K. L., Welsbie, D. S., Biswal, S., & Duh, E. J. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1512683112 · Cited by 92
NO control of mitochondrial function in normal and transformed cells
Tengan, C. H., & Moraes, C. T. (2017) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2017.02.009 · Cited by 92
Advanced multimodal nanoparticles delay tumor progression with clinical radiation therapy
Detappe, A., Kunjachan, S., Sancey, L., Motto‐Ros, V., Biancur, D. E., Drané, P., Guièze, R., Makrigiorgos, G. M., Tillement, O., Langer, R., et al. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.07.021 · Cited by 96
Metadata
- Authors
- Dewhirst, M. W., Cao, Y., & Moeller, B.
- Affiliations
- Duke Medical Center (US)
- Corresponding author
- Dewhirst, Mark W.
- Venue
- Nature Reviews Cancer
- Published
- 2008-06
- Volume
- 8
- Issue
- 6
- Pages
- 425-437
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC3943205
- OpenAlex
- W2016861891
- Cited by
- 1,022
- References
- 161
- Citations by year
- 2026: 27 · 2025: 29 · 2024: 30 · 2023: 52 · 2022: 60 · 2021: 70 · 2020: 76 · 2019: 44 · 2018: 64 · 2017: 53 · 2016: 73 · 2015: 65 · 2014: 63 · 2013: 63 · 2012: 62
- FWCI
- 4.55
- Type
- journal article
- Language
- en
- Update notices
- erratum (2008-07-03)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (CA40355, R01CA040355, P50CA068438)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Kruppel-like factors research
- Keywords
- tumor hypoxia, free radicals, reactive oxygen species, reactive nitrogen species, HIF-1, tumor angiogenesis, radiotherapy response, tumor heterogeneity, immune cell infiltration, tumor cell survival, endothelial cells
- MeSH terms
- Animals, Free Radicals, Humans, Neoplasms, Neovascularization, Pathologic, Nitric Oxide, Oxygen, Cell Hypoxia, Vascular Endothelial Growth Factor A, Hypoxia-Inducible Factor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.